Shares of Boston Scientific Corporation (NYSE:BSX) Sees Large Outflow of Money

Boston Scientific Corporation (NYSE:BSX) surged 0.06% during the last session. The last traded price was up 0.01 points at $17.96. The data for the fund flow suggests that the net intraday money flow was $(-6.22) million. The fund value in upticks was recorded to be $7.84 million and in downticks, it was found to be $14.06 million. The up/down ratio for the day was measured to be 0.56. For the week, the shares have seen a percentage change of 2.05%.A block trade of $(-5.46) million in net money flow was also recorded during the day. For the block, the combined worth of upticks was $1.16 million and that of downticks was $6.62 million. The block tradeoff had the up/down ratio of 0.18.

Boston Scientific Corporation has dropped 2.5% during the last 3-month period . Year-to-Date the stock performance stands at 35.4%. Shares of Boston Scientific Corporation (NYSE:BSX) rose by 1.93% in the past week and 0.56% for the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 0.47%. Boston Scientific Corporation (NYSE:BSX) has underperformed the index by 0.23% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

Boston Scientific Corporation (NYSE:BSX) witnessed a decline in the market cap on Friday as its shares dropped 0.06% or 0.01 points. After the session commenced at $17.92, the stock reached the higher end at $17.99 while it hit a low of $17.81. With the volume soaring to 5,927,482 shares, the last trade was called at $17.94. The company has a 52-week high of $18.62. The company has a market cap of $24,052 million and there are 1,340,676,000 shares in outstanding. The 52-week low of the share price is $11.1.

On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The Officer (SVP&Pres, Uro & Womens Health), of Boston Scientific Corp, Prange Karen had unloaded 17,456 shares at $17.66 per share in a transaction on July 7, 2015. The total value of transaction was $308,273. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Womens Health, Neuromodulation, and Electrophysiology. In November 2013, the Company announced that it has acquired Bard EP, the electrophysiology (EP) business of C.R. Bard, Inc. In February 2014, Boston Scientific Corp acquired StarMedTec GmbH, a Starnberg-based manufacturer of medical laser systems. Effective May 7, 2014, the Company acquired the remaining 72% interest, which it did not already own, in IoGyn Inc.

Shares of Boston Scientific Corporation (NYSE:BSX) Sees Large Outflow of Money